Body Weight and its Impact on Inflammatory Arthritis

Body weight can influence inflammatory arthritis through both physical stress and internal responses. Excess weight increases load on weight-bearing joints, while higher levels of body fat can contribute to chronic low-grade inflammation that may worsen symptoms, disease severity, long-term bone health and reduce the chance of remission.

 

Mechanical Stress on Joints

Higher body weight places additional pressure on joints such as the spine, hips, knees, and ankles. In people with inflammatory arthritis, this added load can increase pain and reduce mobility. Uncontrolled inflammation and mechanical load could lead to bone erosion in already vulnerable joints.

Inflammation and Metabolic Effects

  • Excess body fat can promote meta-inflammation; a chronic low-grade inflammatory state linked with immune and metabolic dysfunction.
  • Fat cells release inflammatory mediators and hormones known as adipokines, which may contribute to joint inflammation.
  • In inflammatory arthritis, higher body weight and obesity have been linked with a lower likelihood of achieving remission and may reduce treatment response
  • Weight management, regular appropriate exercise, and dietary changes can help reduce joint strain, support cardiovascular health, and complement medical treatment.

What to Remember

Body weight is a modifiable factor that can reduce inflammatory arthritis symptoms, meta-inflammation and treatment outcomes. Even small changes in weight (~10%) may improve physical function and quality of life.

Meet the expert

Martin Lau

Martin Lau

Arthritis Action Services Manager and Dietitian

Martin was a Senior Dietitian in the NHS prior to joining Arthritis Action. He is particularly interested in eating patterns, nutrients’ interactions, weight management and persistent pain management in people living with arthritis. As well as being a Dietitian, Martin is also qualified in the field of strength and conditioning. Currently he is a member of the EULAR task force in the non-pharmacological management of Systemic Lupus Erythematosus.

References

  1. Abuhelwa AY, Hopkins AM, Sorich MJ, Proudman S, Foster DJR, Wiese MD. Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs. Sci Rep. 2020 Oct 29;10(1):18634.
  2. Cambré, I., Gaublomme, D., Burssens, A. et al. Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis. Nat Commun 9, 4613 (2018).
  3. Ferrigno, S., Çela, E., Fatica, M. et al. Metabolic challenges in rheumatoid arthritis: a translational overview from pathogenesis to patient care. Acta Diabetol (2026).
  4. Malik M, Gopalakrishnan M, Shukla R, et al AB0618 RELATIONSHIP OF BODY MASS INDEX AND FAT COMPOSITION USING DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA) WITH DISEASE ACTIVITY AND PATIENT REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS Annals of the Rheumatic Diseases 2024;83:1593-1594.

 

medac Pharma provided arm’s length funding for this project. Medac Pharma has had no influence on the project, or the development of any associated materials.